Bin Wu, PhD; Lizheng Shi, PhD, MsPharm, MA
free access
JAMA Dermatol. 2020;156(11):1177-1184. doi:10.1001/jamadermatol.2020.2398
This cost-utility analysis compares the cost-utility of these novel agents and their combinations with or without BRAF gene testing guidance for treating newly diagnosed advanced melanoma with unknown BRAF status.
Vincenzo De Giorgi, MD; Alessia Gori, MD; Lorenzo Salvati, MD; et al.
free access
JAMA Dermatol. 2020;156(11):1185-1191. doi:10.1001/jamadermatol.2020.2528
This case series evaluates the clinical and dermoscopic features of vulvar melanosis and their changes over time.
Tess M. Lukowiak, BS; Leora Aizman, BS; Allison Perz, BS; et al.
free access
JAMA Dermatol. 2020;156(11):1192-1198. doi:10.1001/jamadermatol.2020.2571
This cross-sectional study defines differences in the ratio of basal cell to cutaneous squamous cell carcinomas in US adults in a large database of patients with commercial insurance and Medicare Advantage coverage.
Jeanette Halskou Haugaard, MD; Kristian Kofoed, MD, PhD; Gunnar Gislason, MD, PhD; et al.
free access
JAMA Dermatol. 2020;156(11):1199-1207. doi:10.1001/jamadermatol.2020.2786
This case-control study examines the association between drug use and a subsequent diagnosis of subacute cutaneous lupus erythematosus or systemic lupus erythematosus based on a systematic screening process of the drugs in the Anatomical Therapeutic Chemical classification system in a nationwide setting.
Florence Poizeau, MD; Emmanuel Nowak, PhD; Sandrine Kerbrat, MS; et al.
free access
JAMA Dermatol. 2020;156(11):1208-1215. doi:10.1001/jamadermatol.2020.2977
This case-time-control analysis uses data from the French national health insurance database to assess whether the initiation of ustekinumab treatment is associated with triggering severe cardiovascular events.
Natashia Benzian-Olsson, MSc; Nick Dand, PhD; Charlotte Chaloner, MSc; et al.
open access
JAMA Dermatol. 2020;156(11):1216-1222. doi:10.1001/jamadermatol.2020.3275
This cross-sectional study examines factors that may contribute to the severity of symptoms in patients with palmoplantar pustulosis.